Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02144402 · ClinicalTrials.gov registry record · NA
Growth of Healthy Term Infants Fed Formula Containing DHA-B
A NA study, sponsored by dsm-firmenich Switzerland.
- Completed
- Registry status
- NA
- Development phase
- 159
- Enrollment target
NCT02144402: Completed NA study, sponsored by dsm-firmenich Switzerland.
NCT02144402 is a NA study that has completed, run by dsm-firmenich Switzerland. The registered enrollment target is 159 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02144402, a NA study, has completed, sponsored by dsm-firmenich Switzerland.
- COMPLETED
- Registry status
- NA
- Development phase
- 159 participants
- Enrollment target
Study Summary
The primary objective is to determine if the weight gain of healthy term infants fed a commercially available term infant formula supplemented with DHASCO® is similar to that of infants fed the same formula supplemented with a new product, DHASCO®-B.
Primary Outcome
gm/day -calculated from the weight measured at enrollment subtracted from the weight measured at DOL 120 visit, divided by the number of days between the actual visits.
Interventions
- OTHER infant formula with DHASCO
- OTHER infant formula with DHASCO-B
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2014-05 |
| Est. Completion | 2015-07 |
| Phase | NA |
What the finished NCT02144402 record still lists
NCT02144402 is an interventional study that assigns participants to a tested intervention. The registered 159 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which infant formula with DHASCO is the first listed.
NCT02144402 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02144402 about?
NCT02144402 is a clinical study titled "Growth of Healthy Term Infants Fed Formula Containing DHA-B". The primary objective is to determine if the weight gain of healthy term infants fed a commercially available term infant formula supplemented with DHASCO® is similar to that of infants fed the same formula supplemented with a new product, DHASCO®-B.
What is the current status of trial NCT02144402?
This trial is currently completed. It is a NA study. The enrollment target is 159 participants. The study started on 2014-05. Estimated completion is 2015-07.
What interventions are being tested in trial NCT02144402?
The interventions under investigation include: infant formula with DHASCO (OTHER), infant formula with DHASCO-B (OTHER).
Who is sponsoring clinical trial NCT02144402?
This trial is sponsored by dsm-firmenich Switzerland, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02144402's enrollment target sits among peer trials
159 654th of 2000 higher than 1,347 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05267626 · 159 participants · Phase 1
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- NCT06321575 · 159 participants · NA
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
- NCT06729151 · 159 participants
Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain Syndrome
- NCT07023731 · 159 participants · Phase 1
A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia